Neuland Laboratories Ltd (NEULANDLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 229993,
    "name": "Neuland Labs.",
    "stock_name": "Neuland Labs.",
    "full_name": "Neuland Laboratories Ltd",
    "name_url": "stocks-analysis/neuland-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "17,200.00",
    "chg": 200.25,
    "chgp": "1.18%",
    "dir": 1,
    "prev_price": "16,999.75",
    "mcapval": "21,997.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524558,
    "symbol": "NEULANDLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE794A01010",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "27.0 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/neuland-labs-229993-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Neuland Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-neuland-laboratories-ltd-latest-results-good-or-bad-3989938",
        "imagepath": "",
        "date": "2026-05-13 19:17:02",
        "description": "Neuland Laboratories Ltd has reported its Q4 FY26 financial results, showcasing significant quarter-on-quarter growth. The company achieved net sales of ₹776.25 crores, reflecting a 76.54% increase from the previous quarter, alongside a remarkable net profit of ₹212.67 crores, which represents a 424.21% rise compared to Q3 FY26. This quarter's performance marks a notable turnaround from the preceding quarter, driven by robust revenue growth and substantial improvements in operating margins, which reached 39.59%, the highest in at least seven quarters.\n\nHowever, when viewed in the context of the full fiscal year FY25, the overall performance presents a more complex picture. For the year, Neuland Laboratories reported a decline in revenues of 5.3% to ₹1,476.00 crores and a net profit decrease of 13.33% to ₹260.00 crores compared to FY24. This divergence between the strong quarterly results and the annual perf..."
      },
      {
        "title": "Neuland Laboratories Ltd Sees Robust Trading Activity Amid Sector Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-sees-robust-trading-activity-amid-sector-outperformance-3989076",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NeulandLaborato_most_active_equities_by_value_3989076.png",
        "date": "2026-05-13 10:00:07",
        "description": "Neuland Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 13 May 2026. The stock demonstrated robust investor interest, marked by a significant uptick in traded volume and value, alongside a notable upgrade in its Mojo Grade to ‘Buy’ from ‘Hold’ just days earlier."
      },
      {
        "title": "Neuland Laboratories Ltd Opens 8.11% Higher in Sharp Gap Up, But Can the Technicals Support It?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-opens-strong-with-significant-gap-up-reflecting-positive-market-sentiment-3989062",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NeulandLaborato_gapup_3989062.png",
        "date": "2026-05-13 09:50:07",
        "description": ""
      },
      {
        "title": "Neuland Laboratories Ltd Reports Strong Quarterly Turnaround with Record Revenue and Profit Margins",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-reports-strong-quarterly-turnaround-with-record-revenue-and-profit-margins-3988334",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NeulandLaborato_fintrenddot_3988334.png",
        "date": "2026-05-13 08:00:05",
        "description": "Neuland Laboratories Ltd has delivered a remarkable financial turnaround in the quarter ended March 2026, posting record revenues and operating margins that mark a significant improvement from its previous quarters. The company’s financial trend score surged from a negative -16 to a very positive 28, signalling robust operational performance and renewed investor confidence."
      },
      {
        "title": "Neuland Laboratories Gains 9.65%: 4 Key Factors Driving the Week’s Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-gains-965-4-key-factors-driving-the-weeks-rally-3984224",
        "imagepath": "",
        "date": "2026-05-10 13:00:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Intraday high of Rs.16,460 with a 7.09% surge</p>\n                    <p><strong>5 May:</strong> Technical momentum shifts amid strong price rally</p>\n                    <p><strong>6 May:</strong> Mojo Grade upgraded to Hold as technicals improve</p>\n                    <p><strong>6 May:</strong> Technical momentum signals mildly bullish outlook</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.16,135.75</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.17,693.65</div>..."
      },
      {
        "title": "Neuland Laboratories Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-3976724",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NeulandLaborato_technicaldot_3976724.png",
        "date": "2026-05-06 08:00:38",
        "description": "Neuland Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting cautious optimism among investors as the stock navigates current market conditions."
      },
      {
        "title": "Neuland Laboratories Ltd Sees Technical Momentum Shift Amid Strong Price Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-sees-technical-momentum-shift-amid-strong-price-rally-3974628",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NeulandLaborato_technicaldot_3974628.png",
        "date": "2026-05-05 08:00:58",
        "description": "Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a strong day change of 7.58%, the stock’s technical landscape remains nuanced, with mixed signals from MACD, RSI, moving averages, and other momentum indicators suggesting cautious optimism for investors."
      },
      {
        "title": "Neuland Laboratories Ltd Surges 7.09% to Day's High of Rs 16,460 — Outperforms Sector by 5.81 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-hits-intraday-high-with-709-surge-on-4-may-2026-3974037",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NeulandLaborato_priceRelatedfactors_3974037.png",
        "date": "2026-05-04 11:45:48",
        "description": "The Sensex advanced 0.99% on 4 May 2026, yet Neuland Laboratories Ltd outpaced the broader market with a 7.09% gain, reaching an intraday high of Rs 16,460. This 5.81-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific momentum shift rather than a mere market tailwind."
      },
      {
        "title": "Neuland Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-ltd-is-rated-sell-3968028",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NeulandLaborato_mojoScore_3968028.png",
        "date": "2026-04-29 10:10:53",
        "description": "Neuland Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 April 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 15,
    "sid": "229993",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/neuland-laboratories-229993"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "16-Jun-2026",
      "details": "Copy of Newspaper Publication",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "05-Jun-2026",
      "details": "Intimation about Schedule of Analyst / Institutional Investor Meeting on June 11 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "03-Jun-2026",
      "details": "Intimation about Schedule of Analyst / Institutional Investor Meeting on June 8 & 9 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Neuland Laboratories Ltd has declared <strong>340%</strong> dividend, ex-date: 24 Jul 26",
          "dt": "2026-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Neuland Laboratories Ltd has announced <strong>4:25</strong> rights issue, ex-date: 13 Aug 14",
          "dt": "2014-08-13",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Are Neuland Laboratories Ltd latest results good or bad?

2026-05-13 19:17:02

Neuland Laboratories Ltd has reported its Q4 FY26 financial results, showcasing significant quarter-on-quarter growth. The company achieved net sales of ₹776.25 crores, reflecting a 76.54% increase from the previous quarter, alongside a remarkable net profit of ₹212.67 crores, which represents a 424.21% rise compared to Q3 FY26. This quarter's performance marks a notable turnaround from the preceding quarter, driven by robust revenue growth and substantial improvements in operating margins, which reached 39.59%, the highest in at least seven quarters. However, when viewed in the context of the full fiscal year FY25, the overall performance presents a more complex picture. For the year, Neuland Laboratories reported a decline in revenues of 5.3% to ₹1,476.00 crores and a net profit decrease of 13.33% to ₹260.00 crores compared to FY24. This divergence between the strong quarterly results and the annual perf...

Neuland Laboratories Ltd Sees Robust Trading Activity Amid Sector Outperformance

2026-05-13 10:00:07

Neuland Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 13 May 2026. The stock demonstrated robust investor interest, marked by a significant uptick in traded volume and value, alongside a notable upgrade in its Mojo Grade to ‘Buy’ from ‘Hold’ just days earlier.

Neuland Laboratories Ltd Opens 8.11% Higher in Sharp Gap Up, But Can the Technicals Support It?

2026-05-13 09:50:07

Neuland Laboratories Ltd Reports Strong Quarterly Turnaround with Record Revenue and Profit Margins

2026-05-13 08:00:05

Neuland Laboratories Ltd has delivered a remarkable financial turnaround in the quarter ended March 2026, posting record revenues and operating margins that mark a significant improvement from its previous quarters. The company’s financial trend score surged from a negative -16 to a very positive 28, signalling robust operational performance and renewed investor confidence.

Neuland Laboratories Gains 9.65%: 4 Key Factors Driving the Week’s Rally

2026-05-10 13:00:04

Key Events This Week 4 May: Intraday high of Rs.16,460 with a 7.09% surge 5 May: Technical momentum shifts amid strong price rally 6 May: Mojo Grade upgraded to Hold as technicals improve 6 May: Technical momentum signals mildly bullish outlook Week OpenRs.16,135.75 Week CloseRs.17,693.65...

Neuland Laboratories Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook

2026-05-06 08:00:38

Neuland Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting cautious optimism among investors as the stock navigates current market conditions.

Neuland Laboratories Ltd Sees Technical Momentum Shift Amid Strong Price Rally

2026-05-05 08:00:58

Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a strong day change of 7.58%, the stock’s technical landscape remains nuanced, with mixed signals from MACD, RSI, moving averages, and other momentum indicators suggesting cautious optimism for investors.

Neuland Laboratories Ltd Surges 7.09% to Day's High of Rs 16,460 — Outperforms Sector by 5.81 Percentage Points

2026-05-04 11:45:48

The Sensex advanced 0.99% on 4 May 2026, yet Neuland Laboratories Ltd outpaced the broader market with a 7.09% gain, reaching an intraday high of Rs 16,460. This 5.81-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific momentum shift rather than a mere market tailwind.

Neuland Laboratories Ltd is Rated Sell

2026-04-29 10:10:53

Neuland Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 April 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

View All News